Skip to main content
Premium Trial:

Request an Annual Quote

Novartis Genomics Institute to Develop Assays with Q3DM

NEW YORK, Dec. 13 — Q3DM will collaborate with the Genomics Institute of the Novartis Research Foundation in order to develop multiple assays on its high-throughput microscopy platform, the company said Thursday.

The company and the institute will jointly develop a suite of applications for high-throughput cell-based screening, and develop for commercialization a set of assays, reagents, and software products.

Researchers at the Novartis facility will use the technology to improve their cellular genomics discovery program, said institute director Peter Schultz in a statement. The Genomics Institute, which is funded by the Novartis Research Foundation, focuses on applying functional genomics technologies to immunology, cancer, neuroscience, and virology.

Q3DM is a privately held San Diego, Calif., company that provides high-throughput microscopy platforms and optimized assays. Its core technologies include software and hardware for cellular image analysis, image data management, and fluorescence light source stabilization.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.